These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 12372277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Molecular biology of polyglutamine diseases].
    Owecki M, Kozubski W.
    Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations.
    Wanker EE.
    Biol Chem; 2000; 381(9-10):937-42. PubMed ID: 11076024
    [Abstract] [Full Text] [Related]

  • 6. The CAG-polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology.
    Stoyas CA, La Spada AR.
    Handb Clin Neurol; 2018; 147():143-170. PubMed ID: 29325609
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Huntingtin aggregation and toxicity in Huntington's disease.
    Bates G.
    Lancet; 2003 May 10; 361(9369):1642-4. PubMed ID: 12747895
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular genetics and biomarkers of polyglutamine diseases.
    Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Tanaka F, Adachi H, Sobue G.
    Curr Mol Med; 2008 May 10; 8(3):221-34. PubMed ID: 18473821
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.
    Reis SD, Pinho BR, Oliveira JMA.
    Mol Neurobiol; 2017 Oct 10; 54(8):5829-5854. PubMed ID: 27660272
    [Abstract] [Full Text] [Related]

  • 15. Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis.
    Wyttenbach A.
    J Mol Neurosci; 2004 Oct 10; 23(1-2):69-96. PubMed ID: 15126694
    [Abstract] [Full Text] [Related]

  • 16. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.
    Sánchez I, Mahlke C, Yuan J.
    Nature; 2003 Jan 23; 421(6921):373-9. PubMed ID: 12540902
    [Abstract] [Full Text] [Related]

  • 17. Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
    Naphade S, Tshilenge KT, Ellerby LM.
    Neurotherapeutics; 2019 Oct 23; 16(4):979-998. PubMed ID: 31792895
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.